| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/20/2002 | EP0734253B1 Biphasic capsule formulation |
| 02/20/2002 | EP0719137B1 Viscous surfactant emulsion compositions |
| 02/20/2002 | CN1336828A Composition and method for the enhancement of the efficacy of drugs |
| 02/20/2002 | CN1336827A Medicinal compositions for oral use |
| 02/20/2002 | CN1336823A Compositions having improved delivery of actives |
| 02/20/2002 | CN1336822A Compositions having improved stability |
| 02/20/2002 | CN1336820A Method for producing film-type dosage forms |
| 02/20/2002 | CN1336819A Pharmaceutical mixture comprising a combination of a profen and other active compounds |
| 02/20/2002 | CN1336817A Topical composition comprising N-acetylaldosamines or N-acetylamino acids |
| 02/20/2002 | CN1336219A Gynopathy treating traditional Chinese medicine |
| 02/20/2002 | CN1336218A Prepn. of wetness-evil eliminating and dyspepsia relieving medicine tablet |
| 02/20/2002 | CN1336205A Plaster for treating fracture, soft tissue damage and bruise and its prepn |
| 02/20/2002 | CN1336202A Ointment specially for treating dermatosis |
| 02/20/2002 | CN1336196A Transdermal absorbed medicine for treating periarthritis of shoulder joint |
| 02/20/2002 | CN1336176A :Roxoithromycin suppostory and its prepn. |
| 02/20/2002 | CN1336172A Venoruton injecta specially for intravenous of ethyhdroxirutini |
| 02/20/2002 | CN1336151A Appliance with ball for applying liquid composition |
| 02/20/2002 | CN1079263C Caspule for curing chronic enteritis |
| 02/20/2002 | CN1079259C Nasal cavity paste for preventing influenza |
| 02/20/2002 | CN1079258C Tablet for treating hepatism |
| 02/20/2002 | CN1079257C Medicine powder for treating burn and empyrosis |
| 02/20/2002 | CN1079245C Pill for treating thign-bone ischemic necrosis |
| 02/20/2002 | CN1079236C Tablets contg. anion exchange resin |
| 02/20/2002 | CN1079235C Acetazolamide microemulsion as eyedrops for treating glaucoma and its preparing process |
| 02/20/2002 | CN1079234C Trip;henyl diamidine enteric coated table as vermifuge |
| 02/20/2002 | CN1079232C Unitary vaginal dosage, and its prepn. method |
| 02/20/2002 | CN1079212C Process for preparing carotenoid compositions |
| 02/19/2002 | US6349232 Apparatus and method for dispensing pet care substances |
| 02/19/2002 | US6348609 Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (HODE) or the esters thereof from a mixture containing linoleic acid or the esters thereof |
| 02/19/2002 | US6348589 Certain dinucleotides and their use as modulators of mucociliary clearance and ciliary beat frequency |
| 02/19/2002 | US6348508 Method for treating dry eye |
| 02/19/2002 | US6348503 Conditioning treatment for herpes sores using powder form using echinacea |
| 02/19/2002 | US6348502 Floating barrier layers and bioadhesive films |
| 02/19/2002 | US6348501 Lotions with carriers, capsaicin, lavender oil, myristal myristate |
| 02/19/2002 | US6348495 Administering alkanoyl l-carnitine |
| 02/19/2002 | US6348490 Releasing and forming racemic mixtures |
| 02/19/2002 | US6348469 Solid compositions containing glipizide and polyethylene oxide |
| 02/19/2002 | US6348455 Compound for treatment of psychosis |
| 02/19/2002 | US6348452 Microbiocides, bactericides for gastrointestinal disorders in animals |
| 02/19/2002 | US6348327 Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells |
| 02/19/2002 | US6348264 Process for producing low de starch hydrolysates by nanofiltration fractionation, products obtained thereby, and use of such products |
| 02/19/2002 | US6348229 Food comprising thixotropic composition of unsaturated fat and process for manufacture thereof |
| 02/19/2002 | US6348217 Bleached stable shellac having ph of from 5.0 to 6.8, selected from particulate shellac, delipidized shellac solution or lipidized shellac solution having stable ph when heated |
| 02/19/2002 | US6348216 Ibuprofen and narcotic analgesic compositions |
| 02/19/2002 | US6348214 Materials and methods for making improved liposome compositions |
| 02/19/2002 | US6348213 Intravenously administering liposomes having lipid component comprising phosphatidylcholine having same acyl chains as phosphatidylcholines in heart cells of younger subjects, repeating until drop in serum creatine phosphokinase is noted |
| 02/19/2002 | US6348212 Treating traumatic burns or blisters of the skin |
| 02/19/2002 | US6348211 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 02/19/2002 | US6348210 Methods for transdermal drug administration |
| 02/19/2002 | US6348209 Inhalation comprising an effective amount of a vesicant and a pharmeceutically acceptable carrier, wherein the vesicant does not exhibit substantial toxicity while treating a patient for neoplasm |
| 02/19/2002 | US6348207 Exposing biologically active agent to complexing perturbant to reversibly transform biologically active agent to intermediate state and form orally deliverable supramolecular complex, orally administering complex to subject |
| 02/19/2002 | US6348206 Composition and method for producing lubricating, germicide foam |
| 02/19/2002 | US6348203 Antimicrobial metronidazole and tinidizole in suspension with a polysaccharide, a water miscible alkylene glycolsolvent and water; hydrogel that is less prone to irritate inflamed or sensitive skin |
| 02/19/2002 | US6348186 Preparation of further diagnostic agents |
| 02/19/2002 | US6348184 Contacting inert support material with aqueous solution of radioactive salt of phosphoric acid, whereby radioactive salt is adsorbed on support material and converting salt to corresponding radioactive salt of pyrophosphoric acid |
| 02/19/2002 | US6348090 Film coatings and film coating compositions based on dextrin |
| 02/19/2002 | US6348050 Infusion systems for creating microenvironments in a living body |
| 02/19/2002 | US6347930 Device and method for manufacturing a segmented tubular capsule containing a biologically active medium |
| 02/19/2002 | CA2217948C Metered dose inhaler for fluticasone propionate |
| 02/19/2002 | CA2195065C Inhalation composition |
| 02/19/2002 | CA2192333C Stabilized biologically active compounds contained in coated microgranules which can be suspended in alimentary fluids |
| 02/19/2002 | CA2182030C Use of a bradykinin antagonist in a cosmetic, pharmaceutical or dermatological composition; composition thus obtained |
| 02/19/2002 | CA2165118C Cosmetic or dermatologic composition containing a ceramide mixture; use thereof for skin moisturizing |
| 02/19/2002 | CA2109099C Method and apparatus for forming a transdermal drug device |
| 02/16/2002 | CA2354639A1 Method of making tablets and tablet compositions produced therefrom |
| 02/14/2002 | WO2002012524A2 Adenovirus e1b-55k single amino acid mutants and methods of use |
| 02/14/2002 | WO2002012369A1 Lactic acid polymer and process for producing the same |
| 02/14/2002 | WO2002012266A1 17.beta.-carbothioate 17.alpha.-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents |
| 02/14/2002 | WO2002012265A1 6.ALPHA., 9.ALPHA.-DIFLUORO-17.ALPHA.-`(2-FURANYLCARBOXYL) OXY!-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-ANDROST-1,4,-DIENE-17-CARBOTHIOIC ACID S-FLUOROMETHYL ESTER AS AN ANTI-INFLAMMATORY AGENT |
| 02/14/2002 | WO2002012258A1 New immunoeffector compounds |
| 02/14/2002 | WO2002012188A2 Indole compounds useful for the treatment of cancer |
| 02/14/2002 | WO2002011803A1 Electro-powder |
| 02/14/2002 | WO2002011778A1 System and method for intranasal administration of opioids |
| 02/14/2002 | WO2002011772A2 Radiolabelled metal transport proteins as imaging agents |
| 02/14/2002 | WO2002011768A1 Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| 02/14/2002 | WO2002011766A2 Use of 5ht4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation |
| 02/14/2002 | WO2002011764A2 Pharmaceutical compositions |
| 02/14/2002 | WO2002011753A1 Protein injection preparations |
| 02/14/2002 | WO2002011740A2 'slow release' pharmaceutical compositions comprising lithium carbonate |
| 02/14/2002 | WO2002011735A2 Association of a purine activity and a nonsteroidal anti-inflammatory anti-inflammatory drug for treating sexual dysfunction |
| 02/14/2002 | WO2002011733A1 Pharmaceutical composition comprising condensed indole compound |
| 02/14/2002 | WO2002011730A1 Radiosensitising agent for curing oncological diseases |
| 02/14/2002 | WO2002011728A2 Pharmaceutical compositions of anti-tubercular drugs and process for their preparation |
| 02/14/2002 | WO2002011727A1 Stable pergolide mesylate and process for making same |
| 02/14/2002 | WO2002011726A1 Highly absorbable solid preparation |
| 02/14/2002 | WO2002011716A2 Liquid formulation of metformin |
| 02/14/2002 | WO2002011711A2 Formulations of mometasone and a bronchodilator for pulmonary administration |
| 02/14/2002 | WO2002011710A2 Pharmaceutical compositions of cholesteryl ester transfer protein inhibitors |
| 02/14/2002 | WO2002011709A2 Pharmaceutical, effervescent formulation containing ramipril |
| 02/14/2002 | WO2002011703A1 Hybrid neuroprosthesis for the treatment of brain disorders |
| 02/14/2002 | WO2002011702A2 Hydrogel-driven drug dosage form |
| 02/14/2002 | WO2002011701A1 A controlled release pharmaceutical composition |
| 02/14/2002 | WO2002011699A1 Drug delivery system for enhanced bioavailability of hydrophobic active ingredients |
| 02/14/2002 | WO2002011698A1 Novel compositions of minoxidil |
| 02/14/2002 | WO2002011697A1 A method of preparing a pharmaceutical composition |
| 02/14/2002 | WO2002011695A2 Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation |
| 02/14/2002 | WO2002011694A2 Compositions and dosage forms for application in the oral cavity in the treatment of mykoses |
| 02/14/2002 | WO2002011683A1 Topical gel delivery system |
| 02/14/2002 | WO2002011671A2 Method of preparing stable bleached shellac |
| 02/14/2002 | WO2002011669A2 Compositions comprising heat shock proteins or alpha(2)macroglobulin, antigenic molecules and saponins, and methods of use thereof |